| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/30/2014 | WO2014017599A1 Novel t cell epitope peptide of japanese cypress pollen allergen |
| 01/30/2014 | WO2014016787A2 Peptide-based compounds and uses thereof to treat beta-amyloid accumulation |
| 01/30/2014 | WO2014016455A1 Variants of the calcium-sensitive fusion protein tdtomato-aequorin |
| 01/30/2014 | WO2013158644A3 Targeted therapeutics |
| 01/30/2014 | US20140031523 Selective Poly-N-Substituted Glycine Antibiotics |
| 01/30/2014 | US20140031296 New synthetic peptides and their use |
| 01/30/2014 | US20140031293 Therapeutic agents with improved fibrinogen binding |
| 01/30/2014 | US20140031277 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/30/2014 | US20140030820 Triazacyclononane-based phosphinate ligand and its use for molecular imaging |
| 01/30/2014 | US20140030283 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
| 01/30/2014 | US20140030242 Antifungal composition comprising polycyclic peptide compound and method for preparing the same |
| 01/29/2014 | EP2690107A2 Cyclic peptides with an anti-neoplasic and anti-angiogenic activity |
| 01/29/2014 | EP2688904A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
| 01/29/2014 | CN103539841A Separation and purification method of cyclohexanol peptide compound and salt thereof |
| 01/29/2014 | CN103539840A Epidermal growth factor receptor (EGFR) mimotope peptide and application thereof |
| 01/29/2014 | CN103539839A Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof |
| 01/29/2014 | CN103539838A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl RGD peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539837A 1-methyl-beta-carbolinyl-3-formyl RGD peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539836A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl YIGS peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539835A 1-methyl-tetrahydro-beta-carbolinyl-3-formyl YIGS peptides, and synthesis, nano structure, antithrombotic action and application thereof |
| 01/29/2014 | CN103539834A Chemerin derived peptide and expressed gene and application thereof |
| 01/29/2014 | CN102746382B B-cell epitope peptide of heart fatty acid binding protein (H-FABP), antibody and applications thereof |
| 01/29/2014 | CN102617707B Preparation method of new homologue 2-methyl-actinomycin D of actinomycin D |
| 01/29/2014 | CN102234316B Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof |
| 01/29/2014 | CN101448850B Immunomodulating oligopeptides |
| 01/28/2014 | US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 01/28/2014 | US8637471 Fertilization prediction and promotion |
| 01/28/2014 | US8637463 Peptide inhibiting angiotensin converting enzyme |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | CA2502690C Compstatin analogs with improved activity |
| 01/28/2014 | CA2456593C Peptides for the diagnosis, monitoring and treatment of diabetes |
| 01/23/2014 | WO2014015181A2 Metal abstraction peptide with release of metal |
| 01/23/2014 | WO2014014206A1 Novel peptide tag and uses thereof |
| 01/23/2014 | US20140024810 Modified Antibody Compositions, Methods of Making and Using Thereof |
| 01/23/2014 | US20140024606 Peptidomimetics comprising n-amino cyclic urea residues and uses thereof |
| 01/23/2014 | US20140024605 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 01/23/2014 | US20140024596 Disease inhibiting agent |
| 01/23/2014 | US20140024593 Treatments of Gastrointestinal Disorders |
| 01/23/2014 | US20140023672 Foxm1 peptide and medicinal agent comprising the same |
| 01/23/2014 | US20140023671 Tomm34 peptides and vaccines including the same |
| 01/23/2014 | US20140023666 Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof |
| 01/22/2014 | EP2687541A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/22/2014 | EP2687540A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 01/22/2014 | EP2687537A1 Polypeptide drug against hepatitis b virus x protein |
| 01/22/2014 | EP2687206A1 Targeting of EWS-FLI1 as anti-tumor therapy |
| 01/22/2014 | EP2687203A1 Emulsified composition for dilution and cancer vaccine composition |
| 01/22/2014 | EP2686338A2 Functionalized biomaterials for tissue regeneration |
| 01/22/2014 | EP2686337A1 Oligopeptides and process for preparation thereof |
| 01/22/2014 | CN103534271A Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 01/22/2014 | CN103534265A Cyclic peptides with an anti-neoplasic and anti-angiogenic activity |
| 01/22/2014 | CN103533995A Method for purification of micafungin |
| 01/22/2014 | CN103524603A A method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit |
| 01/22/2014 | CN103524602A Application of antibacterial peptide in pharmacy |
| 01/22/2014 | CN103524601A Epitope peptide in human spawn ZP (zona pellucida) protein 4 and application of epitope peptide |
| 01/22/2014 | CN103524600A New cyclic lipopeptides locillomycin A, B and C and preparation method thereof |
| 01/22/2014 | CN103524599A Cyclopeptide luteinizing hormone releasing hormone (LHRH) antagonist derivatives and pharmaceutical use thereof |
| 01/22/2014 | CN103524597A Antioxidant peptide prepared from shark prolamin and preparation method and application thereof |
| 01/22/2014 | CN103524506A Preparation method and application of radioiodine labeled biomolecules |
| 01/22/2014 | CN102432674B Method for purifying cyclic lipopeptide compound or salt thereof |
| 01/22/2014 | CN102268066B Anti-HBV oligopeptides and derivatives thereof |
| 01/22/2014 | CN102241735B Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof |
| 01/21/2014 | US8633224 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 01/21/2014 | US8633163 Template-fixed peptidomimetics |
| 01/21/2014 | US8632992 Methods for assaying enzyme activities |
| 01/21/2014 | US8632972 Methods and compositions for identifying RNA-binding proteins |
| 01/21/2014 | US8632753 Multivalent constructs for therapeutic and diagnostic applications |
| 01/21/2014 | CA2665748C Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/21/2014 | CA2583494C 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/16/2014 | WO2014012093A1 Prostate cancer targeted prodrugs and methods of use thereof |
| 01/16/2014 | WO2014010971A1 Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| 01/16/2014 | WO2014010721A1 Method of producing self-assembling peptide derivative |
| 01/16/2014 | WO2014009025A1 Methods for synthesizing amatoxin building block and amatoxins |
| 01/16/2014 | WO2013177231A8 Translocation of non-natural chemical entities through anthrax protective antigen pore |
| 01/16/2014 | US20140018545 Inhibitors of Dipeptidylpeptidase IV |
| 01/16/2014 | US20140018307 Linaclotide compositions |
| 01/16/2014 | US20140017248 Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection |
| 01/16/2014 | CA2878081A1 Methods for synthesizing amatoxin building block and amatoxins |
| 01/15/2014 | EP2684888A1 Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method |
| 01/15/2014 | EP2684865A1 Methods for synthesizing amatoxin building block and amatoxins |
| 01/15/2014 | EP2684568A2 EEF2-derived peptides for the treatment or prevention of cancer |
| 01/15/2014 | CN103517915A Method for preparing Buserelin |
| 01/15/2014 | CN103509090A Protein glpks4 involved in pneumocandin synthesis, and its coding gene |
| 01/15/2014 | CN103509088A Novel amphiphilic ionic polypeptide and application thereof in cell culture aspect |
| 01/15/2014 | CN103509087A Application of anti-CiP antibody in diagnosis of early rheumatoid arthritis |
| 01/15/2014 | CN103509086A Function epitope of botulinum toxin, monoclonal antibody binding to its specificity and applications thereof |
| 01/15/2014 | CN102964427B Bioactive polypeptide QEPVL, and preparation and application thereof |
| 01/14/2014 | US8629244 Interleukin-6 receptor binding polypeptides |
| 01/14/2014 | US8629241 Alpha helical mimics, their uses and methods for their production |
| 01/14/2014 | US8629239 Methylocystis strain SB2 materials and methods |
| 01/14/2014 | US8629114 Compositions and methods for transport across the blood brain barrier |
| 01/14/2014 | US8629106 Affinity peptides toward BMP-2 |
| 01/14/2014 | US8629097 Macromolecule transduction domains and methods for identification and uses thereof |
| 01/14/2014 | CA2426312C Compositions and methods for modulating rsv infection and immunity |
| 01/09/2014 | WO2014007584A1 Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban |
| 01/09/2014 | WO2014007547A1 Novel peptides and use thereof |
| 01/09/2014 | WO2014007506A1 Igg fc position-selective binding peptides and hybrid molecules comprising same |
| 01/09/2014 | WO2014007266A1 Transdermal cancer antigen peptide preparation |
| 01/09/2014 | WO2014006262A1 Composition containing polypeptides for the treatment of myiasis |